Back to newsRapport Therapeutics: Wells Fargo cuts target price to $47 from $50RRAPP•2026-11-05Wells Fargo cut its target price for Rapport Therapeutics to $47 from $50.Related NewsEUK's midcap index at record high ahead of Bank of England rate callEWU•2026-11-05BBCE Q3 adjusted EPS USD 0.74BCE•2026-11-05TTeleflex declares quarterly dividend of $0.34 per shareTFX•2026-11-05PPlaytika Q3 net income rises to $40.4 million as revenue falls to $673.8 millionPLTK•2026-11-05BBCE reaffirms 2026 financial guidanceBCE•2026-11-05
RAPP•RAPP•RAPP•RAPP•
